|Articles|October 15, 2013

Structural Forces Impacting the Pharmaceutical Industry

Patrick Lindsay, president of UBC sits down with Editorial Director William Looney to discusses the issues UBC confronts as it offers support services to pharmaceutical companies


Patrick Lindsay, president of UBC sits down with Editorial Director Bill Loony to discusses the issues UBC confronts as it offers support services to pharmaceutical companies.


Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.